Skip to Main Content

Paper Details

Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups.
Gynecol Oncol
8
2022
-, -EMSC, 95 loci, BRCA1, BRCA2, CCNE1, EEC, EMSC, EMSCs, ERBB2, Endometrial serous carcinoma, FBXW7, HRD, MYC, PARP, PIK3CA, PPP2R1A, TMB, TP53, TP53 mutations, endometrial serous carcinoma, endometrioid-type endometrial carcinomas, gLOH, homologous recombination deficiency, ovarian carcinoma, patients, uterine cancer
Author NameAffiliation
Jonathan K KillianFoundation Medicine Inc.
Jonathan K KillianFoundation Medicine Inc.
Shakti H RamkissoonFoundation Medicine Inc., United States of America Wake Forest Comprehensive Cancer Center and Department of Pathology, Wake Forest School of Medicine
Jeffrey S RossFoundation Medicine Inc., United States of America Upstate Medical University
  • 1 - 4

Datasets

Release 1.2